The deal reinforces GSK’s leadership in respiratory care and builds upon the company’s expanding COPD portfolio
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
Pharma CDMO business has posted a 40% YoY in Q2 driven by BD efforts and backed by macro tailwinds
New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids
This aims to benefit approximately 4.5 crore families with six crore senior citizens with Rs. 5 lakh free health insurance cover on a family basis
Novartis has option to acquire two future development-ready programs to augment its renal portfolio, a strategic area of focus for the company
This strong performance was primarily on account of a one-time gain from the strategic collaboration between Biocon Biologics and Eris Lifesciences.
Subscribe To Our Newsletter & Stay Updated
